OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ALKS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Alkermes (ALKS) Earnings Date & Reports

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ALKS is expected to report earnings to fall 14.40% to 44 cents per share on October 22

Q3'25

Est.

$0.45

Q2'25

Beat

by $0.16

Q1'25

Missed

by $0.18

Q4'24

Beat

by $0.30

Q3'24

Beat

by $0.01

The last earnings report on July 29 showed earnings per share of 51 cents, beating the estimate of 36 cents. With 1.57M shares outstanding, the current market capitalization sits at 4.80B.

View a ticker or compare two or three

Compare

ALKS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ALKS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALKS showed earnings on July 29, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile

Fundamentals

Details

Industry

Biotechnology

Address

1 Burlington Road

Phone

+353 17728000

Employees

2100

Web

https://www.alkermes.com